Epinastine Hydrochloride

Spezifikationen

108929-04-0CAS-Nummer

629-843-8EG-Nummer

2,4-diazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine;hydrochlorideIUPAC-Name

C16H16ClN3Chemische Formel

285.77 g/molMolekulargewicht

Epinastine hydrochloride; 108929-04-0; Epinastine HCl; Alesion; Elestat; WAL-801CL; WAL 801 CL; Relestat; DTXSID1046502; GFM415S5XL; DE-114; WAL-802-CL; DTXCID9026502; CHEBI:51037; WAL 801CL; RefChem:56562; 9,13b-Dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepin-3-amine hydrochloride; 80012-44-8; 9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine hydrochloride; MFCD00933434; Epinastine hydrochloride [JAN]; Epinastine (hydrochloride); WAL801; 2,4-diazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine;hydrochloride; 3-Amino-9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepine Hydrochloride; 9,13b-Dihydro-1H-dibenz[cf]imidazo[1,5-a]azepine hydrochloride; Epinastine hydrochloride (JAN); 1H-Dibenz[c,f]imidazo[1,5-a]azepin-3-amine, 9,13b-dihydro-,hydrochloride; Epinastine monohydrochloride; CAS-108929-04-0; NCGC00165791-02; UNII-GFM415S5XL; Flurinol; (13bRS)-9,13b-Dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine hydrochloride; 1H-Dibenz[c,f]imidazo[1,5-a]azepin-3-amine, 9,13b-dihydro-, monohydrochloride (9CI); Alesion; Elestat; Epinastine hydrochloride; WAL 801CL; Alesion (TN); Elestat (TN); epinastin hydrochloride; Epinastini Hydrochloride; 3-Amino-9,13b-dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepine monohydrochloride; Epinastine hydrochloride CRS; SCHEMBL122749; HY-B0640AR; orb1300724; CHEMBL1200491; SCHEMBL30678575; HY-B0640A; HMS3652N21; HMS3885B15; HMS5082B20; Epinastine HCl - Bio-X trade mark; EX-A1004; Tox21_112263; Tox21_500501; EBC-28051; EPINASTINE HYDROCHLORIDE [MI]; s4253; AKOS015967222; Epinastine (hydrochloride) (Standard); Tox21_112263_1; AC-1491; CCG-221805; FE31358; KS-1159; LP00501; Epinastine for system suitability A CRS; EPINASTINE HYDROCHLORIDE [MART.]; IH-Dibenz(c,f)imidazo(1,5-a)azepin-3-amine, 9,13b-dihydro-, monohydrochloride; EPINASTINE HYDROCHLORIDE [USP-RS]; EPINASTINE HYDROCHLORIDE [WHO-DD]; NCGC00165791-04; NCGC00261186-01; BE300075; SY107475; DB-040850; CS-0013220; E0799; SW220223-1; T6488; EPINASTINE HYDROCHLORIDE [ORANGE BOOK]; D01713; EPINASTINE HYDROCHLORIDE [EP MONOGRAPH]; F17420; EN300-7365601; Epinastine hydrochloride, >=98% (HPLC), solid; Q27122286; Z2756516876; Epinastine hydrochloride, European Pharmacopoeia (EP) Reference Standard; 1H-DIBENZ(C,F)IMIDAZO(1,5-A)AZEPIN-3-AMINE, 9,13B-DIHYDRO-, HYDROCHLORIDE (1:1); 1H-Dibenz[c,f]imidazo[1,5-a]azepin-3-amine,9,13b-dihydro-, hydrochloride (1:1); 3-AMINO-9,13B-DIHYDRO-1H-DIBENZ(C,F)IMIDAZO(1,5-A)AZEPINE HYDROCHLORIDE, DL-; 9,13b-Dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepin-3-amine hydrochloride;108929-04-0; 9,13b-Dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine--hydrogen chloride (1/1); Epinastine hydrochloride, United States Pharmacopeia (USP) Reference Standard; 2,4-diazatetracyclo[12.4.0.0^{2,6}.0^{7,12}]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine hydrochloride; 2,4-Diazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine;hydron;chloride; Epinastine hydrochloride for system suitability, European Pharmacopoeia (EP) Reference StandardSynonyme